Research graph
References from Long‐Term Patient‐Reported Outcomes and Dosimetric Predictors of Quality of Life After Curative‐Intent Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: A Cross‐Sectional Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Prevalence of Human Papillomavirus in Oropharyngeal and Nonoropharyngeal Head and Neck Cancer—Systematic Review and Meta‐Analysis of Trends by Time and Region
10.1002/hed.22015 · 2013 · External reference
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
10.1200/jco.2011.36.4596 · 2011 · External reference
Improved Survival of Patients With Human Papillomavirus‐Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
10.1093/jnci/djn011 · 2008 · External reference
Distinct Risk Factor Profiles for Human Papillomavirus Type 16‐Positive and Human Papillomavirus Type 16‐Negative Head and Neck Cancers
10.1093/jnci/djn025 · 2008 · External reference
Human Papillomavirus and Survival of Patients With Oropharyngeal Cancer
10.1056/nejmoa0912217 · 2010 · External reference
Human Papillomavirus Vaccination Coverage in Children Ages 9‐17 Years: United States, 2022
2024 · External reference
Dysphagia‐Optimised Intensity‐Modulated Radiotherapy Versus Standard Intensity‐Modulated Radiotherapy in Patients With Head and Neck Cancer (DARS): A Phase 3, Multicentre, Randomised, Controlled Trial
10.1016/s1470-2045(23)00265-6 · 2023 · External reference
Parotid‐Sparing Intensity Modulated Versus Conventional Radiotherapy in Head and Neck Cancer (PARSPORT): A Phase 3 Multicentre Randomised Controlled Trial
10.1016/s1470-2045(10)70290-4 · 2011 · External reference
Health‐Related Quality of Life in 640 Head and Neck Cancer Survivors After Radiotherapy Using EORTC QLQ‐C30 and QLQ‐H&N35 Questionnaires
10.1186/1471-2407-11-128 · 2011 · External reference
Toxicities in Long‐Term Survivors of Head and Neck Cancer‐A Multi‐National Cross‐Sectional Analysis
10.1002/ijc.70033 · 2025 · External reference
Head and Neck Cancer: A Review
10.1001/jama.2025.21733 · 2026 · External reference
Patient‐Reported Toxicity and Quality‐Of‐Life Profiles in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy or Chemoradiation
10.1016/j.ijrobp.2021.05.114 · 2021 · External reference
Non‐Metastatic Squamous Cell Carcinoma of the Oropharynx: Primary Surgery or (Chemo)radiotherapy?
10.1002/hed.70356 · 2026 · External reference
Radiation Therapy for HPV‐Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline
10.1016/j.prro.2024.05.007 · 2024 · External reference
Unresolved reference
2026 · External reference
Delineation of the Neck Node Levels for Head and Neck Tumors: A 2013 Update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG Consensus Guidelines
10.1016/j.radonc.2013.10.010 · 2014 · External reference
Selection of Lymph Node Target Volumes for Definitive Head and Neck Radiation Therapy: A 2019 Update
10.1016/j.radonc.2019.01.018 · 2019 · External reference
Delineation of the Primary Tumour Clinical Target Volumes (CTV‐P) in Laryngeal, Hypopharyngeal, Oropharyngeal and Oral Cavity Squamous Cell Carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG‐KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG Consensus Guidelines
10.1016/j.radonc.2017.10.016 · 2018 · External reference
International Validation of the Revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ‐HN43: Phase IV
10.1002/hed.25609 · 2019 · External reference
Comparing Adaptive and Dose Redistributed Radiotherapy to Conventional Radiotherapy in Head and Neck Cancer‐Quality of Life Results From the Phase III ARTFORCE Trial
10.1016/j.radonc.2025.111044 · 2025 · External reference
The Clinical Significance of Quality of Life Assessments in Oncology: A Summary for Clinicians
10.1007/s00520-006-0085-y · 2006 · External reference
General Population Normative Data for the EORTC QLQ‐C30 Health‐Related Quality of Life Questionnaire Based on 15,386 Persons Across 13 European Countries, Canada and the Unites States
10.1016/j.ejca.2018.11.024 · 2019 · External reference
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long‐Term Results of the ORATOR Trial
10.1200/jco.21.01961 · 2022 · External reference
Phase II Randomized Trial of Transoral Surgery and Low‐Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG‐ACRIN Cancer Research Group Trial (E3311)
10.1200/jco.21.01752 · 2022 · External reference
Reduced‐Dose Radiation Therapy for HPV‐Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
10.1200/jco.20.03128 · 2021 · External reference
Patient Assessed Symptoms Are Poor Predictors of Objective Findings. Results From a Cross Sectional Study in Patients Treated With Radiotherapy for Pharyngeal Cancer
10.1080/02841860701491041 · 2007 · External reference
Long‐Term Patient‐Reported Outcomes in a Population‐Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer
10.1001/jamaoto.2023.1323 · 2023 · External reference
Unresolved reference
2025 · External reference
